James Shaughnessy Sells 12,000 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) insider James Shaughnessy sold 12,000 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total transaction of $546,480.00. Following the transaction, the insider owned 52,815 shares in the company, valued at approximately $2,405,195.10. This trade represents a 18.51% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Down 0.5%

Shares of Docusign stock opened at $45.77 on Friday. The company has a 50 day moving average price of $46.89 and a 200 day moving average price of $50.93. The firm has a market capitalization of $8.74 billion, a P/E ratio of 29.72, a PEG ratio of 1.36 and a beta of 0.90. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $86.65.

Docusign (NASDAQ:DOCU) last released its earnings results on Thursday, June 4th. The company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The company had revenue of $830.24 million for the quarter, compared to the consensus estimate of $824.71 million. During the same quarter in the previous year, the firm earned $0.90 EPS. Docusign’s revenue was up 8.7% compared to the same quarter last year. As a group, research analysts anticipate that Docusign Inc. will post 2.03 earnings per share for the current fiscal year.

Docusign announced that its board has approved a stock buyback program on Tuesday, March 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to purchase up to 21% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on DOCU shares. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Citizens Jmp dropped their price target on Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a research note on Wednesday, March 18th. Weiss Ratings lowered Docusign from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, June 26th. Wells Fargo & Company cut their price objective on Docusign from $60.00 to $55.00 and set an “equal weight” rating on the stock in a report on Friday, June 5th. Finally, JPMorgan Chase & Co. reduced their price objective on Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $60.27.

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Central Pacific Bank Trust Division purchased a new position in shares of Docusign during the 4th quarter valued at about $25,000. Modus Advisors LLC purchased a new stake in shares of Docusign in the fourth quarter worth about $27,000. Torren Management LLC purchased a new stake in shares of Docusign in the fourth quarter worth about $28,000. Aventura Private Wealth LLC purchased a new stake in shares of Docusign in the fourth quarter worth about $30,000. Finally, True Wealth Design LLC grew its holdings in Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks boosted longer-term earnings expectations for DocuSign, including higher FY2027, FY2028, and future quarterly EPS estimates, which suggests improving profitability over time.
• Positive Sentiment: DocuSign highlighted its AI assistant and agents at Momentum London 2026, signaling ongoing product innovation and an effort to strengthen its platform in the AI-driven workflow market. Docusign showcases AI assistant and agents at Momentum London 2026 to power the next era of agreement work
• Neutral Sentiment: DocuSign is also being pitched by Zacks as a long-term value idea, reflecting a favorable valuation case rather than a clear near-term catalyst. Why DocuSign (DOCU) is a Top Value Stock for the Long-Term
• Negative Sentiment: Multiple executives, including CEO Allan C. Thygesen, CFO Blake Jeffrey Grayson, and CRO Paula Hansen, sold shares under pre-arranged 10b5-1 plans, which can weigh on investor sentiment even if the sales were planned.
• Negative Sentiment: Paula Hansen’s additional 6,000-share sale was separately reported again this morning, keeping insider selling in focus for traders. Paula Hansen Sells 6,000 Shares of Docusign (NASDAQ:DOCU) Stock

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.